318 results
8-K
EX-5.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
having made any special investigation as to the applicability of another statute, law, rule or regulation. None of the opinions or other advice contained
8-K
EX-1.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
of any claim under any environmental laws and the Company is not aware of any pending investigation that could reasonably be expected to lead … by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. Notwithstanding the foregoing
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
on our experience in the industry and our own investigation of market conditions. We believe these estimates to be accurate as of the date
424B2
gjv s190n3p
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
mp5dmdlrjzg0afrx
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
60v5q ji4
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-5.1
7s3z9
13 Nov 23
Other Events
4:19pm
8-K
EX-1.1
570b4 xb2
13 Nov 23
Other Events
4:19pm
424B5
myem03
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
c5i0bo53t6fyvql3dcv2
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
f0sxfc4oz5x7
10 Apr 23
Additional proxy soliciting materials
5:12pm